This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

George G. Rhoads, MD, MPH; Gosta Dahlen, MD, PhD; Kare Berg, MD, PhD; Newton E. Morton, PhD; Andrew L. Dannenberg, MD, MPH

JAMA. 1986;256(18):2540-2544.

Abstract
The Lp(a) lipoprotein is structurally related to low-density lipoprotein but is found in lower plasma concentration. It has been associated with coronary disease in several white populations. To test the generalizability of this association, we measured serum Lp(a) by quantitative immunoelectrophoresis in 303 Hawaiian men of Japanese ancestry with a prior myocardial infarction (MI) and in 408 population-based controls. Mean values were 17.1 and 13.7 mg/dL (0.171 and 0.137 g/L) respectively. Increased risk for MI was shown mainly for men in the upper quartile of the Lp(a) lipoprotein distribution (20.1 mg/dL [0.201 g/L]). Odds ratios at younger than 60, 60 to 69, and 70 years of age or older were 2.5, 1.6, and 1.2 times those for men in the lower three quartiles, respectively. In a multiple logistic model the association with MI remained significant and was not explained by differences in total cholesterol levels, high-density lipoprotein or low-density lipoprotein cholesterol levels, subscapular skin fold, systolic blood pressure, history of smoking, alcohol consumption, or age. We conclude that Lp(a) is an important attribute that should often be considered when coronary heart disease risk is assessed.

(JAMA 1986;256:2540-2544)

Author Affiliations
From the Institute of Medical Genetics, University of Oslo (Dr Berg); the Department of Medicine, Baylor College of Medicine, Houston (Dr Dahlen); the Honolulu Heart Study, Kuakini Medical Center, and the Population Genetics Laboratory, University of Hawaii, Honolulu (Dr Morton); and the National Institute of Child Health and Human Development (Dr Rhoads) and the National Heart, Lung, and Blood Institute (Dr Dannenberg), Bethesda, Md.

Footnotes
Reprint requests to Epidemiology Branch, National Institute of Child Health and Human Development, Landow Bldg, Room 8A-04, Bethesda, MD 20892 (Dr Rhoads).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Determination of lipoprotein(a) kringle repeat number from genomic DNA: copy number variation genotyping using qPCR
Lanktree et al.
J. Lipid Res. 2009;50:768-772.
ABSTRACT | FULL TEXT  

A Physiological Function for Apolipoprotein(a): A Natural Regulator of the Inflammatory Response
Hoover-Plow et al.
Exp. Biol. Med. 2009;234:28-34.
ABSTRACT | FULL TEXT  

Oxidized Phospholipids, Lipoprotein(a), Lipoprotein-Associated Phospholipase A2 Activity, and 10-Year Cardiovascular Outcomes: Prospective Results From the Bruneck Study
Kiechl et al.
Arterioscler. Thromb. Vasc. Bio. 2007;27:1788-1795.
ABSTRACT | FULL TEXT  

Aortic valve calcification in systemic lupus erythematosus
Kiani et al.
Lupus 2006;15:873-876.
ABSTRACT  

Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women.
Suk Danik et al.
JAMA 2006;296:1363-1370.
ABSTRACT | FULL TEXT  

Relation Between Lipoprotein(a) and Fibrinogen and Serial Intravascular Ultrasound Plaque Progression in Left Main Coronary Arteries
Hartmann et al.
J Am Coll Cardiol 2006;48:446-452.
ABSTRACT | FULL TEXT  

Apo[a] size and PNR explain African American-Caucasian differences in allele-specific apo[a] levels for small but not large apo[a]
Rubin et al.
J. Lipid Res. 2006;47:982-989.
ABSTRACT | FULL TEXT  

Oxidized Phospholipids, Lp(a) Lipoprotein, and Coronary Artery Disease
Tsimikas et al.
NEJM 2005;353:46-57.
ABSTRACT | FULL TEXT  

Lipoprotein(a): An Elusive Cardiovascular Risk Factor
Berglund and Ramakrishnan
Arterioscler. Thromb. Vasc. Bio. 2004;24:2219-2226.
ABSTRACT | FULL TEXT  

Diabetic Cardiomyopathy: Evidence, Mechanisms, and Therapeutic Implications
Fang et al.
Endocr. Rev. 2004;25:543-567.
ABSTRACT | FULL TEXT  

Apolipoprotein(a) Size and Lipoprotein(a) Concentration and Future Risk of Angina Pectoris with Evidence of Severe Coronary Atherosclerosis in Men: The Physicians' Health Study
Rifai et al.
Clin. Chem. 2004;50:1364-1371.
ABSTRACT | FULL TEXT  

Long-Term Effects of Lipoprotein(a) on Carotid Atherosclerosis in Elderly Japanese
Iwamoto et al.
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2004;59:M62-67.
ABSTRACT | FULL TEXT  

Prediction of Short-Term Progression or Regression of Atherosclerotic Coronary Artery Disease by Lipoprotein (a): A Quantitative Coronary Angiographic Study
Uchida et al.
ANGIOLOGY 2003;54:641-646.
ABSTRACT  

Lipoprotein(a), Chlamydia pneumoniae, leptin and tissue plasminogen activator as risk markers for valvular aortic stenosis
Glader et al.
Eur Heart J 2003;24:198-208.
ABSTRACT | FULL TEXT  

Apolipoprotein [a] genotype influences isoform dominance pattern differently in African Americans and Caucasians
Rubin et al.
J. Lipid Res. 2002;43:234-244.
ABSTRACT | FULL TEXT  

Stimulation of Interleukin-8 Production in Human THP-1 Macrophages by Apolipoprotein(a). EVIDENCE FOR A CRITICAL INVOLVEMENT OF ELEMENTS IN ITS C-TERMINAL DOMAIN
Klezovitch et al.
J. Biol. Chem. 2001;276:46864-46869.
ABSTRACT | FULL TEXT  

Moderate alcohol consumption and coronary heart disease: a review
Hines and Rimm
Postgrad. Med. J. 2001;77:747-752.
FULL TEXT  

Fluorescence-based, Nonradioactive Method for Efficient Detection of the Pentanucleotide Repeat (TTTTA)n Polymorphism in the Apolipoprotein(a) Gene
Rubin et al.
Clin. Chem. 2001;47:1758-1762.
ABSTRACT | FULL TEXT  

Lipoprotein(a) and Cognitive Performances in an Elderly White Population : Cross-Sectional and Follow-Up Data
Sarti et al.
Stroke 2001;32:1678-1683.
ABSTRACT | FULL TEXT  

Antifibrinolytic effect of single apo(a) kringle domains: relationship to fibrinogen binding
Rahman et al.
Protein Eng Des Sel 2001;14:427-438.
ABSTRACT | FULL TEXT  

Lipoprotein (a) up-regulates the expression of the plasminogen activator inhibitor 2 in human blood monocytes
Buechler et al.
Blood 2001;97:981-986.
ABSTRACT | FULL TEXT  

High Levels of Lp(a) With a Small Apo(a) Isoform Are Associated With Coronary Artery Disease in African American and White Men
Paultre et al.
Arterioscler. Thromb. Vasc. Bio. 2000;20:2619-2624.
ABSTRACT | FULL TEXT  

The proatherogenic properties of lipoprotein(a) may be enhanced through the formation of circulating immune complexes containing Chlamydia pneumoniae -specific IgG antibodies
Glader et al.
Eur Heart J 2000;21:639-646.
ABSTRACT  

Homocysteine and Lipoprotein(a) Interact to Increase CAD Risk in Young Men and Women
Foody et al.
Arterioscler. Thromb. Vasc. Bio. 2000;20:493-499.
ABSTRACT | FULL TEXT  

Effect of Individual Plasma Lipoprotein(a) Variations In Vivo on Its Competition With Plasminogen for Fibrin and Cell Binding : An In Vitro Study Using Plasma From Children With Idiopathic Nephrotic Syndrome
Soulat et al.
Arterioscler. Thromb. Vasc. Bio. 2000;20:575-584.
ABSTRACT | FULL TEXT  

Dissecting the Genetic Architecture of Lipids, Lipoproteins, and Apolipoproteins : Lessons From Twin Studies
Snieder et al.
Arterioscler. Thromb. Vasc. Bio. 1999;19:2826-2834.
ABSTRACT | FULL TEXT  

Chlamydia pneumoniae Antibodies and High Lipoprotein(a) Levels Do Not Predict Ischemic Cerebral Infarctions : Results From a Nested Case-Control Study in Northern Sweden
Glader et al.
Stroke 1999;30:2013-2018.
ABSTRACT | FULL TEXT  

Potential New Cardiovascular Risk Factors: Left Ventricular Hypertrophy, Homocysteine, Lipoprotein(a), Triglycerides, Oxidative Stress, and Fibrinogen
Harjai
ANN INTERN MED 1999;131:376-386.
ABSTRACT | FULL TEXT  

Lipoprotein(a)-Cholesterol and Coronary Heart Disease in the Framingham Heart Study
Seman et al.
Clin. Chem. 1999;45:1039-1046.
ABSTRACT | FULL TEXT  

Effect of Lp(a) on the Early Functional and Structural Changes of Atherosclerosis
Raitakari et al.
Arterioscler. Thromb. Vasc. Bio. 1999;19:990-995.
ABSTRACT | FULL TEXT  

Lipoprotein(a) and dietary proteins: casein lowers lipoprotein(a) concentrations as compared with soy protein
Nilausen and Meinertz
Am. J. Clin. Nutr. 1999;69:419-425.
ABSTRACT | FULL TEXT  

Association between apolipoprotein(a) phenotypes and coronary heart disease at a young age
Gazzaruso et al.
J Am Coll Cardiol 1999;33:157-163.
ABSTRACT | FULL TEXT  

Association of Apolipoprotein A Phenotypes and Oxidized Low-Density Lipoprotein Immune Complexes in Children
Islam et al.
Arch Pediatr Adolesc Med 1999;153:57-62.
ABSTRACT | FULL TEXT  

Lipoprotein(a) and inflammation in human coronary atheroma: association with the severity of clinical presentation
Dangas et al.
J Am Coll Cardiol 1998;32:2035-2042.
ABSTRACT | FULL TEXT  

Lipoprotein(a) as a risk factor for ischemic heart disease: metaanalysis of prospective studies
Craig et al.
Clin. Chem. 1998;44:2301-2306.
ABSTRACT | FULL TEXT  

Inhibition of N-linked glycosylation results in retention of intracellular apo[a] in hepatoma cells, although nonglycosylated and immature forms of apolipoprotein[a] are competent to associate with apolipoprotein B-100 in vitro
Bonen et al.
J. Lipid Res. 1998;39:1629-1640.
ABSTRACT | FULL TEXT  

Molecular basis of an apolipoprotein[a] null allele: a splice site mutation is associated with deletion of a single exon
Cox et al.
J. Lipid Res. 1998;39:1319-1326.
ABSTRACT | FULL TEXT  

The Relationship of Various Factors in the Pathogenesis of Atherosclerosis
Sonmez et al.
CLIN APPL THROMB HEMOST 1998;4:105-110.
ABSTRACT  

Characterization of Multiple Enhancer Regions Upstream of the Apolipoprotein(a) Gene
Wade et al.
J. Biol. Chem. 1997;272:30387-30399.
ABSTRACT | FULL TEXT  

Lipoprotein(a) Interactions With Lipid and Nonlipid Risk Factors in Early Familial Coronary Artery Disease
Hopkins et al.
Arterioscler. Thromb. Vasc. Bio. 1997;17:2783-2792.
ABSTRACT | FULL TEXT  

Relation between lipoprotein(a) concentrations in patients with acute-phase response and risk analysis for coronary heart disease
Min et al.
Clin. Chem. 1997;43:1891-1895.
ABSTRACT | FULL TEXT  

Plasma Lipoprotein (a) Levels in Men and Women Consuming Diets Enriched in Saturated, Cis-, or Trans-Monounsaturated Fatty Acids
Clevidence et al.
Arterioscler. Thromb. Vasc. Bio. 1997;17:1657-1661.
ABSTRACT | FULL TEXT  

Genetic Variation in Factor VII Associated with Variation in Plasma Lipoprotein(a) Concentration
Hegele et al.
Arterioscler. Thromb. Vasc. Bio. 1997;17:1701-1706.
ABSTRACT | FULL TEXT  

Hormonal Regulation of Lipoprotein(a) Levels: Effects of Estrogen Replacement Therapy on Lipoprotein(a) and Acute Phase Reactants in Postmenopausal Women
Tuck et al.
Arterioscler. Thromb. Vasc. Bio. 1997;17:1822-1829.
ABSTRACT | FULL TEXT  

Should We Measure Lipoprotein Lp(a)?
Wilson and Kannel
Arch Intern Med 1997;157:1161-1162.
ABSTRACT  

Lipoprotein Lp(a) Excess and Coronary Heart Disease
Stein and Rosenson
Arch Intern Med 1997;157:1170-1176.
ABSTRACT  

Feedback Mechanism of Focal Vascular Lesion Formation in Transgenic Apolipoprotein(a) Mice
Lawn et al.
J. Biol. Chem. 1996;271:31367-31371.
ABSTRACT | FULL TEXT  

Lipoprotein(a) Assembly: Quantitative Assessment of the Role of Apo(a) Kringle IV Types 2-10 in Particle Formation
Gabel et al.
Arterioscler. Thromb. Vasc. Bio. 1996;16:1559-1567.
ABSTRACT | FULL TEXT  

Lack of Increased Coronary Atherosclerotic Risk Due to Elevated Lipoprotein(a) in Women >=55 Years of Age
Sunayama et al.
Circulation 1996;94:1263-1268.
ABSTRACT | FULL TEXT  

Elevated Plasma Lipoprotein(a) and Coronary Heart Disease in Men Aged 55 Years and Younger: A Prospective Study
Bostom et al.
JAMA 1996;276:544-548.
ABSTRACT  

Lipoprotein(a) in Patients With Acute Cerebral Ischemia
van Kooten et al.
Stroke 1996;27:1231-1235.
ABSTRACT | FULL TEXT  

Effect of Oral Estradiol on Lp(a) and Other Lipoproteins in Postmenopausal Women: A Randomized, Double-blind, Placebo-Controlled, Crossover Study
Haines et al.
Arch Intern Med 1996;156:866-872.
ABSTRACT  

Secondary Prevention of Coronary Heart Disease in Patients with Extracoronary Atherosclerosis: A Need for Accuracy of Low Density Lipoprotein Determination
Senti et al.
ANGIOLOGY 1996;47:241-246.
ABSTRACT  

Race and Gender Differences in the Association of Lp(a) With Carotid Artery Wall Thickness : The Atherosclerosis Risk in Communities (ARIC) Study
Schreiner et al.
Arterioscler. Thromb. Vasc. Bio. 1996;16:471-478.
ABSTRACT | FULL TEXT  

Lp(a) Levels and Atherosclerotic Vascular Disease in a Sample of Patients With Familial Hypercholesterolemia Sharing the Same Gene Defect
Carmena et al.
Arterioscler. Thromb. Vasc. Bio. 1996;16:129-136.
ABSTRACT | FULL TEXT  

Effects of Lowering Elevated LDL Cholesterol on the Cardiovascular Risk of Lipoprotein(a)
Maher et al.
JAMA 1995;274:1771-1774.
ABSTRACT  

Familial Hypobetalipoproteinemia Is Not Associated With Low Levels of Lipoprotein(a)
Averna et al.
Arterioscler. Thromb. Vasc. Bio. 1995;15:2165-2175.
ABSTRACT | FULL TEXT  

Lipoprotein(a) and Asymptomatic Carotid Artery Disease : Evidence of a Prominent Role in the Evolution of Advanced Carotid Plaques: The Bruneck Study
Willeit et al.
Stroke 1995;26:1582-1587.
ABSTRACT | FULL TEXT  

Dose-Response Relationships of Serum Lipid Measurements With the Extent of Coronary Stenosis : Strong, Independent, and Comprehensive
Bolibar et al.
Arterioscler. Thromb. Vasc. Bio. 1995;15:1035-1042.
ABSTRACT | FULL TEXT  

Hormonal Regulation of Serum Lipoprotein(a) Levels : Contrasting Effects of Growth Hormone and Insulin-Like Growth Factor–I
Olivecrona et al.
Arterioscler. Thromb. Vasc. Bio. 1995;15:847-849.
ABSTRACT | FULL TEXT  

No Association Between Plasma Lipoprotein(a) Concentrations and the Presence or Absence of Coronary Atherosclerosis in African-Americans
Moliterno et al.
Arterioscler. Thromb. Vasc. Bio. 1995;15:850-855.
ABSTRACT | FULL TEXT  

Plasma Concentration of Lipoprotein(a) and the Risk of Future Stroke
Ridker et al.
JAMA 1995;273:1269-1273.
ABSTRACT  

Identification of Two Functionally Distinct Lysine-binding Sites in Kringle 37 and in Kringles 32-36 of Human Apolipoprotein(a)
Ernst et al.
J. Biol. Chem. 1995;270:6227-6234.
ABSTRACT | FULL TEXT  

Genetic Basis of Lipoprotein Disorders
Dammerman and Breslow
Circulation 1995;91:505-512.
FULL TEXT  

C/T Polymorphism in the 5' Untranslated Region of the Apolipoprotein(a) Gene Introduces an Upstream ATG and Reduces In Vitro Translation
Zysow et al.
Arterioscler. Thromb. Vasc. Bio. 1995;15:58-64.
ABSTRACT | FULL TEXT  

Nicotinic Acid as a Lipoprotein-Altering Agent: Therapy Directed by the Primary Physician
Probstfield and Hunninghake
Arch Intern Med 1994;154:1557-1559.
ABSTRACT  

Lipoprotein(a) and Risk of Myocardial Infarction
Gaw
JAMA 1994;271:1077-1077.
ABSTRACT  

A Prospective Study of Lipoprotein(a) and the Risk of Myocardial Infarction
Ridker et al.
JAMA 1993;270:2195-2199.
ABSTRACT  

Lipoprotein(a): A New Risk Factor for Vascular Disease
Valentine
PERSPECT VASC SURG ENDOVASC THER 1992;5:84-99.
 

Lipoprotein(a) and Atherosclerosis
Scanu et al.
ANN INTERN MED 1991;115:209-218.
ABSTRACT  

Serum Levels of Lipoprotein(a) in Patients With Well-Controlled Non-Insulin-Dependent Diabetes Mellitus
Joven and Vilella
JAMA 1991;265:1113-1114.
ABSTRACT  

Lovastatin, Pravastatin, and Serum Lipoprotein(a)
Jacob et al.
ANN INTERN MED 1990;112:713-714.
ABSTRACT  

Increased Serum Levels of Lipoprotein(a) in Diabetes Mellitus and Their Reduction With Glycemic Control
Bruckert et al.
JAMA 1990;263:35-36.
ABSTRACT